Selegiline (Deprenyl): The Complete Guide to the MAO-B Inhibitor

Your brain produces an enzyme that destroys dopamine every single day. That enzyme is called monoamine oxidase type B, and in 2026, one medication can selectively shut it down. Selegiline cognitive enhancement has become a topic of intense interest among people seeking dopaminergic support, but this is a prescription medication with serious risks that demands your full attention and medical supervision.

You need to understand something right now. Selegiline is not a supplement you order online. It’s a prescription drug approved for Parkinson’s disease, and using it without physician oversight can land you in the emergency room or worse.

What Is Selegiline (Deprenyl)?

Selegiline goes by several brand names depending on how you take it. Eldepryl is the oral tablet form, Zelapar dissolves on your tongue, and Emsam comes as a transdermal patch you wear on your skin. The generic name is selegiline, though some people still call it by its research name, deprenyl.

The drug does one thing exceptionally well at standard doses. It selectively blocks MAO-B, the specific enzyme isoform responsible for breaking down dopamine in your brain. By inhibiting this enzyme, selegiline allows dopamine to stick around longer in the synaptic space where your neurons communicate.

This selectivity matters more than you might think. Older MAO inhibitors blocked both MAO-A and MAO-B, creating dangerous interactions with common foods containing tyramine. Selegiline’s selectivity for MAO-B means you avoid those dietary restrictions at therapeutic doses, but that selectivity disappears when people chase higher doses for selegiline cognitive enhancement effects.

The FDA approved selegiline specifically for Parkinson’s disease. That’s the only indication on the label, and that’s where the clinical evidence lives. Everything else exists in a gray zone of off-label use that your doctor may or may not support.

How Selegiline Works

MAO-B Selective Inhibition

Your brain contains two versions of monoamine oxidase. MAO-A primarily breaks down serotonin, norepinephrine, and tyramine from your diet. MAO-B focuses on dopamine and phenylethylamine, though it can metabolize other substrates too.

Selegiline at doses of 10mg or less per day selectively inhibits MAO-B. This selectivity preserves dopamine levels without interfering with MAO-A’s job of handling dietary tyramine and other monoamines. The result is increased dopaminergic activity in brain regions where dopamine matters most for movement, motivation, and cognitive function.

The dopamine preservation effect is why Parkinson’s patients take this medication. Their disease kills dopamine-producing neurons in the substantia nigra, and selegiline helps them squeeze more mileage from the dopamine they still produce. The same mechanism drives interest in selegiline cognitive enhancement among people who don’t have Parkinson’s but want dopaminergic support.

MAO-A Inhibition at Higher Doses

Here’s where things get dangerous. Above 10mg daily, selegiline loses its selectivity. At 20mg, 30mg, or higher doses that some people experiment with, the drug starts inhibiting MAO-A just as aggressively as MAO-B.

When MAO-A inhibition kicks in, you’re now taking a full MAOI. That means the tyramine in aged cheese, cured meats, fermented foods, and draft beer can trigger a hypertensive crisis. Your blood pressure can spike to stroke levels within minutes of eating the wrong food.

The loss of selectivity also dramatically increases the risk of serotonin syndrome when combined with other medications. This isn’t a theoretical concern or a rare side effect. It’s a predictable pharmacological consequence of taking doses that exceed the selectivity threshold.

Neuroprotective Mechanisms

Selegiline does more than just block MAO-B. When MAO-B breaks down dopamine, it produces hydrogen peroxide as a metabolic byproduct. Hydrogen peroxide generates oxidative stress that damages neurons over time.

By reducing dopamine metabolism, selegiline cuts hydrogen peroxide production. Less oxidative stress means less cumulative damage to dopaminergic neurons. This mechanism has made researchers wonder if selegiline might slow neurodegenerative processes in aging brains.

Some studies suggest selegiline activates anti-apoptotic pathways independently of MAO-B inhibition. The drug may trigger cellular survival signals that protect neurons from programmed cell death. These effects remain under investigation, and the clinical significance for selegiline cognitive enhancement in healthy adults is unclear.

CRITICAL DRUG INTERACTION WARNING ⚠️

This section could save your life. Read every word.

Selegiline at any dose carries a serious risk of serotonin syndrome when combined with serotonergic medications. Serotonin syndrome is not a mild side effect. It’s a potentially fatal condition that can progress from confusion and agitation to seizures, hyperthermia, and death within hours.

You absolutely cannot take selegiline with SSRIs like fluoxetine, sertraline, or escitalopram. You cannot combine it with SNRIs like venlafaxine or duloxetine. Tramadol, a common pain medication, is contraindicated. Meperidine (Demerol) combined with selegiline has caused deaths, not just hospitalizations.

The meperidine interaction deserves special emphasis. Multiple fatalities have occurred when patients on selegiline received meperidine for pain. The interaction is swift, severe, and can be lethal. If you take selegiline, you must inform every healthcare provider, including emergency room staff, anesthesiologists, and dentists.

Migraine medications called triptans also interact with selegiline. St. John’s Wort, an over-the-counter supplement, is serotonergic and contraindicated. Dextromethorphan, found in many cough syrups, can trigger serotonin syndrome in combination with MAO inhibitors.

You need a washout period between stopping serotonergic medications and starting selegiline. Most physicians require at least two weeks, and five weeks for fluoxetine due to its long half-life. This is not optional. This is not overly cautious. This is the standard of care that prevents deaths.

Who Uses Selegiline?

The primary legitimate user population is Parkinson’s disease patients. Neurologists prescribe selegiline as an adjunct to levodopa therapy or as monotherapy in early-stage disease. These patients take the medication under close medical supervision with regular follow-up appointments and monitoring.

Some older adults without Parkinson’s use selegiline under physician supervision for dopaminergic neuroprotection. The rationale is that dopamine levels decline with normal aging, and preserving dopamine might support cognitive function and motivation. The evidence for this use is limited, and most physicians won’t prescribe selegiline for this indication.

The off-label interest in selegiline cognitive enhancement exists primarily in online communities focused on nootropics and life extension. People in these communities discuss using selegiline to enhance focus, motivation, and mental energy through dopaminergic mechanisms. This use lacks FDA approval, robust clinical evidence in healthy adults, and carries all the risks discussed in this guide.

You should not use selegiline without a prescription and ongoing physician supervision. The drug interactions alone make self-medication extremely dangerous. Add the cardiovascular effects, the loss of selectivity at higher doses, and the potential for abuse, and you have a medication that demands medical oversight.

Dosage Reference

Parkinson’s patients typically start at 5mg twice daily, taken at breakfast and lunch. The lunch timing matters because selegiline can interfere with sleep if taken later in the day. The total daily dose is usually 10mg, split into two administrations.

Some physicians prescribe 10mg once daily in the morning. This simplified dosing improves compliance but may increase the risk of sleep disturbance. The maximum recommended dose for maintaining MAO-B selectivity is 10mg per day.

Above 10mg daily, you enter full MAOI territory. That means strict dietary restrictions to avoid tyramine-containing foods. Aged cheeses, cured meats, fermented soy products, draft beer, and many other common foods become dangerous. One meal with high tyramine content can trigger a hypertensive crisis that sends you to the emergency room.

The Emsam transdermal patch comes in 6mg, 9mg, and 12mg per 24-hour formulations. The 6mg patch maintains MAO-B selectivity without dietary restrictions. The 9mg and 12mg patches require tyramine restrictions because they deliver doses that inhibit MAO-A.

Zelapar orally disintegrating tablets are dosed at 1.25mg or 2.5mg once daily. The sublingual absorption bypasses first-pass metabolism, potentially allowing lower doses to achieve therapeutic effects. Even with these lower doses, all the interaction warnings still apply.

Frequently Asked Questions

Can I take selegiline with my SSRI antidepressant?

No. Absolutely not. This combination can cause serotonin syndrome, a potentially fatal condition. You need a washout period of at least two weeks (five weeks for fluoxetine) between stopping an SSRI and starting selegiline. This decision requires physician supervision.

Will selegiline improve my focus and motivation if I don’t have Parkinson’s?

The evidence for selegiline cognitive enhancement in healthy adults is limited and mostly anecdotal. The medication is approved only for Parkinson’s disease. Any cognitive effects in healthy people are off-label, unproven, and come with all the risks of a prescription MAO inhibitor.

What happens if I take more than 10mg per day?

You lose MAO-B selectivity and start inhibiting MAO-A as well. This means you need to follow strict dietary restrictions to avoid tyramine, which can cause dangerous blood pressure spikes. The risk of serotonin syndrome with other medications also increases significantly.

Can I drink alcohol while taking selegiline?

Alcohol interactions with selegiline are complex. At selective doses, moderate alcohol consumption may be tolerated, but alcohol can interact unpredictably with MAO inhibitors. Some alcoholic beverages, particularly draft beer and red wine, contain tyramine. Discuss alcohol use with your prescribing physician.

How long does it take for selegiline to start working?

In Parkinson’s patients, symptomatic benefits may appear within a few weeks. For any theoretical selegiline cognitive enhancement effects, the timeline is unclear because this use lacks proper clinical study. Neuroprotective effects, if they exist, would accumulate over months or years.

Is selegiline safe for long-term use?

Parkinson’s patients take selegiline for years under medical supervision. Long-term safety data exists for this population at therapeutic doses. Safety in healthy adults using the medication off-label for cognitive enhancement is unknown because this use hasn’t been properly studied.

The Bottom Line on Dopamine Protection

Selegiline selectively preserves dopamine in your brain by blocking the enzyme that breaks it down. That’s a powerful mechanism with real therapeutic value for Parkinson’s patients. The medication works, and it works through a well-understood pharmacological pathway.

But power demands respect. Selegiline carries serious interaction risks that can kill you if you combine it with the wrong medications. The serotonin syndrome risk is real, documented, and potentially fatal. The meperidine interaction has caused deaths, not just bad reactions.

The interest in selegiline cognitive enhancement exists in a space between legitimate medical use and unsupported experimentation. You won’t find robust clinical trials showing that selegiline improves focus, motivation, or mental performance in healthy adults. You’ll find anecdotes, theories, and a lot of people willing to experiment on themselves.

If you’re considering selegiline, you need a physician who will prescribe it, monitor you, and help you navigate the interaction risks. You need to be honest about every medication and supplement you take. You need to understand that doses above 10mg daily require dietary restrictions that most people can’t or won’t follow consistently.

This isn’t a nootropic you add to your morning stack. It’s a prescription MAO inhibitor with a specific approved indication and a risk profile that demands medical supervision. Treat it accordingly, or don’t use it at all.